Literature DB >> 2554917

Identification of functional beta-adrenergic receptors on AC glioma cells.

W G Conroy1, R W Peoples, G E Isom.   

Abstract

AC glioma cells, a clonal cell line derived from a rat glioma, responded to 1 mM dibutyryl-cyclic AMP and isobutylmethylxanthine with a change to stellate morphology. A concentration-related morphological change was induced by beta 1- and beta 2-adrenergic agonists with the order of potency being isoproterenol greater than soterenol greater than norepinephrine. Propranolol (nonselective, beta-antagonist), butoxamine (beta 2-antagonist) and metoprolol (beta 1-antagonist) significantly decreased the cell response to isoproternol. Schild analysis of the response, using the competitive antagonist metoprolol, gave pA2 values of 7.5 and 8.5 for the agonists norepinephrine and soterenol, respectively, with slopes of the curves being less than unity. These observations indicate that both beta 1- and beta 2-adrenergic receptors mediate the change in cellular morphology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554917     DOI: 10.1016/0006-2952(89)90610-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

Review 1.  Beta-blockers and glioma: a systematic review of preclinical studies and clinical results.

Authors:  Ishaan Ashwini Tewarie; Joeky T Senders; Alexander F C Hulsbergen; Stijn Kremer; Marike L D Broekman
Journal:  Neurosurg Rev       Date:  2020-03-14       Impact factor: 3.042

Review 2.  β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.

Authors:  George Zaki Ghali; Michael George Zaki Ghali
Journal:  Mol Biol Rep       Date:  2020-04-18       Impact factor: 2.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.